He also touted the AI opportunity for Amazon Web Services (AWS), saying that he expected the technology to lead to "tens of billions of dollars in revenue over the next several years". Smaller cloud rival Microsoft rose 1.5%, while Alphabet was down about 1.3%.Īmazon CEO Andy Jassy said on Thursday the cloud business was stabilizing as large expansions with existing customers and first-time agreements were likely to aid growth in the final three months of the year. The e-commerce giant was on track to add almost $90 billion to its market capitalization based on its last traded share price of $128. NIH PATHWAY TO INDEPENDENCE AWARD (PARENT K99/R00 INDEPENDENT CLINICAL TRIAL NOT ALLOWED) RUTH L.(Reuters) rose 7% on Friday on a pick up in growth at its most profitable cloud business as it aims for a larger share of the booming artificial intelligence market in a race with Microsoft. NIAID 2023 DMID OMNIBUS BAA (HHS-NIH-NIAID-BAA2023-1), RESEARCH AREA 004 - DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS, AND EMERGING INFECTIOUS DISEASES (N01)ĭEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES, RESEARCH AREA 002 - DEVELOPMENT OF THERAPEUTIC CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES NIAID INVESTIGATOR INITIATED CLINICAL TRIAL APPLICATIONS AND PROGRAM PROJECTS NIAID 2023 DMID OMNIBUS BAA (HHS-NIH-NIAID-BAA2023-1), RESEARCH AREA 002 - DEVELOPMENT OF THERAPEUTIC CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES (N01) NIAID 2023 DMID OMNIBUS BAA (HHS-NIH-NIAID-BAA2023-1), RESEARCH AREA 001 - DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES (N01) SEXUALLY TRANSMITTED INFECTIONS (STI) COOPERATIVE RESEARCH CENTERS (CRC): VACCINE DEVELOPMENT (U01 CLINICAL TRIAL NOT ALLOWED)ĮXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL), RFP: 75N93022R00034 RESEARCH AND DEVELOPMENT OF VACCINES AND MONOCLONAL ANTIBODIES FOR PANDEMIC PREPAREDNESS (REVAMPP) NETWORK - COORDINATION AND DATA SHARING CENTER (CDSC) (UG3/UH3 CLINICAL TRIAL NOT ALLOWED) RATIONAL SYSTEMATIC CHARACTERIZATION AND SELECTION OF ADJUVANTS FOR HIV VACCINE CANDIDATES (R-CASA) NIHAI75N93023R00003: PRE-CLINICAL MODELS OF INFECTIOUS DISEASES-TASK AREA B RESEARCH AND DEVELOPMENT OF VACCINES AND MONOCLONAL ANTIBODIES FOR PANDEMIC PREPAREDNESS (REVAMPP) CENTERS FOR FLAVIVIRIDAE AND TOGAVIRIDAE (U19 CLINICAL TRIAL NOT ALLOWED) GENOMICS CENTERS FOR INFECTIOUS DISEASES (U19 CLINICAL TRIAL NOT ALLOWED) LARGE SCALE T CELL IMMUNE EPITOPE DISCOVERY AND MECHANISMS OF T CELL PROTECTION (N01) GLOBAL INFECTIOUS DISEASE RESEARCH ADMINISTRATION DEVELOPMENT AWARD FOR LOW-AND MIDDLE-INCOME COUNTRY INSTITUTIONS (G11 CLINICAL TRIAL NOT ALLOWED) NIHAI75N93023R00003: PRE-CLINICAL MODELS OF INFECTIOUS DISEASES- TASK AREA A NIHAI75N93023R00003: PRE-CLINICAL MODELS OF INFECTIOUS DISEASES-TASK AREA D NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED) NIHAI75N93023R00003: PRE-CLINICAL MODELS OF INFECTIOUS DISEASES-TASK AREA CĪLLERGY, IMMUNOLOGY, AND TRANSPLANTATION RESEARCH COMMITTEE (AITC) SPECIAL EMPHASIS PANELĬOOPERATIVE CENTERS ON HUMAN IMMUNOLOGY (U19 CLINICAL TRIAL OPTIONAL) RESEARCH AND DEVELOPMENT OF VACCINES AND MONOCLONAL ANTIBODIES FOR PANDEMIC PREPAREDNESS (REVAMPP) CENTERS FOR BUNYAVIRALES, PARAMYXOVIRIDAE AND PICORNOVIRIDAE (U19 CLINICAL TRIAL NOT ALLOWED)ĬONSORTIUM FOR FOOD ALLERGY RESEARCH, CLINICAL RESEARCH UNITS (U01 CLINICAL TRIAL REQUIRED)ĬONSORTIUM FOR FOOD ALLERGY RESEARCH: LEADERSHIP CENTER (UM1 CLINICAL TRIAL REQUIRED) SUPPORT FOR RESEARCH EXCELLENCE (SURE) AWARD (R16 – CLINICAL TRIAL NOT ALLOWED) INTERNATIONAL CENTERS OF EXCELLENCE FOR MALARIA RESEARCH (U19 CLINICAL TRIAL NOT ALLOWED) NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT NIAID RESEARCH EDUCATION PROGRAM ADVANCING THE CAREERS OF A DIVERSE RESEARCH WORKFORCE (R25 CLINICAL TRIAL NOT ALLOWED) SYNTHETIC NUCLEIC ACID PLATFORMS FOR HIV-1 (SNAPH): (R61/R33 CLINICAL TRIAL NOT ALLOWED) NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) LIMITED COMPETITION: COLLABORATIVE PARTNERSHIP TO ADVANCE GLOBAL HEALTH RESEARCH (U01 CLINICAL TRIAL NOT ALLOWED) INTERNATIONAL RESEARCH IN INFECTIOUS DISEASES (R01 CLINICAL TRIAL NOT ALLOWED) NIAID RESEARCH EDUCATION PROGRAM (R25 CLINICAL TRIAL NOT ALLOWED) NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (PARENT R13 CLINICAL TRIAL NOT ALLOWED) NIAID CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRIAL NOT ALLOWED) AND NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED) To view other meetings from ZAI1 choose calendar year:ĬLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)ĪUTOIMMUNITY CENTERS OF EXCELLENCE, BASIC RESEARCH PROGRAM (U19 CLINICAL TRIAL NOT ALLOWED)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |